SCNX (Scienture Holdings) ROCE %: -16.90% (As of Mar. 2026)

What is Scienture Holdings ROCE %?

Scienture Holdings SCNX -3.56% 47 ROCE % is -16.90% as of Mar. 2026. GuruFocus rates SCNX with a GF Score™ of 47/100 and a GF Value™ of $0.35 (Fairly Valued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Scienture Holdings's annualized ROCE % for the quarter that ended in Mar. 2026 was -16.90%.

Scienture Holdings (NAS:SCNX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Scienture Holdings ROCE % Related Terms

Scienture Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Scienture Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scienture Holdings ROCE % Chart

Scienture Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-76.75

-64.56

-577.95

-35.63

-44.20

Scienture Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-9.78	-24.83	-7.44	-130.38	-16.90

47GF Score

Scienture Holdings Inc SCNX

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Scienture Holdings ROCE % Calculation

Scienture Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-39.424	/	( ( (104.854 - 7.907)	+	(84.178 - 2.735) )	/ 2 )
	=	-39.424	/	( (96.947	+	81.443)	/ 2 )
	=	-39.424	/	89.195
	=	-44.20 %

Scienture Holdings's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-13.46	/	( ( (84.178 - 2.735)	+	(80.662 - 2.804) )	/ 2 )
	=	-13.46	/	( ( 81.443	+	77.858 )	/ 2 )
	=	-13.46	/	79.6505
	=	-16.90 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -16.90% mean?

Scienture Holdings (SCNX) has a ROCE % of -16.90% as of Mar. 2026.

Is Scienture Holdings' ROCE % too high?

Scienture Holdings' current ROCE % is -16.90%. Overall, Scienture Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Scienture Holdings' ROCE % compare to WGRX and HEWA?

Scienture Holdings' ROCE % of -16.90% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scienture Holdings's current ROCE % is -16.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Scienture Holdings stock overvalued right now?

Based on GuruFocus' analysis, Scienture Holdings (SCNX) is currently considered Fairly Valued. The stock's GF Value™ is $0.35, compared to a current price of $0.37 — trading 6.3% above its estimated fair value. The current ROCE % is -16.90%. Scienture Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Scienture Holdings (SCNX), the current ROCE % is -16.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scienture Holdings (SCNX) Overvalued in 2026?

Based on GuruFocus' analysis, Scienture Holdings stock appears to be overvalued. The current stock price of $0.37 is trading 6.3% above its estimated GF Value™ of $0.35. GuruFocus considers Scienture Holdings to be Fairly Valued.

Key valuation signals for SCNX:

ROCE %: -16.90%
GF Value™: $0.35 vs. price of $0.37 (6.3% above fair value)
GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the SCNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scienture Holdings Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies WGRX HEWA BLMH DHTI PMHS RDGT SHFH PETS BHIC HKSE:06618 HKSE:00241 BSP:RADL3 TSE:3088 TSE:3391 SHSE:603939 SAU:4164 JSE:CLS TSE:7649 TSE:3349 SHSE:603233

Other Exchanges 4E4:Germany

Address 20 Austin Boulevard, Commack, NY, USA, 11725

Website https://www.scienture.com

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

47GF Score

Get the complete analysis for SCNX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37

Price

$0.35

GF Value

View SCNX Analysis

See ROCE % data for all stocks →